<VariationArchive VariationID="7390" VariationName="NM_172107.4(KCNQ2):c.2127del (p.Val710fs)" VariationType="Deletion" Accession="VCV000007390" Version="11" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-06-23" DateCreated="2015-08-07" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="22429" VariationID="7390">
      <GeneList>
        <Gene Symbol="KCNQ2" FullName="potassium voltage-gated channel subfamily Q member 2" GeneID="3785" HGNC_ID="HGNC:6296" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="63400208" stop="63472655" display_start="63400208" display_stop="63472655" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NT_187625.1" start="183" stop="33239" display_start="183" display_stop="33239" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="62037541" stop="62103992" display_start="62037541" display_stop="62103992" Strand="-" />
          </Location>
          <OMIM>602235</OMIM>
          <Haploinsufficiency last_evaluated="2013-07-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-07-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_172107.4(KCNQ2):c.2127del (p.Val710fs)</Name>
      <CanonicalSPDI>NC_000020.11:63407135:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20q13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="62038489" stop="62038489" display_start="62038489" display_stop="62038489" variantLength="1" positionVCF="62038488" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="63407136" stop="63407136" display_start="63407136" display_stop="63407136" variantLength="1" positionVCF="63407135" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>V710fs</ProteinChange>
      <ProteinChange>V679fs</ProteinChange>
      <ProteinChange>V682fs</ProteinChange>
      <ProteinChange>V692fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.62038489del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.62038489del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.63407136del" Assembly="GRCh38">
            <Expression>NC_000020.11:g.63407136del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009004.2" sequenceAccession="NG_009004" sequenceVersion="2" change="g.70505del">
            <Expression>NG_009004.2:g.70505del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004518.6" sequenceAccession="NM_004518" sequenceVersion="6" change="c.2043del">
            <Expression>NM_004518.6:c.2043del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004509.2" sequenceAccession="NP_004509" sequenceVersion="2" change="p.Val682fs">
            <Expression>NP_004509.2:p.Val682fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_172106.3" sequenceAccession="NM_172106" sequenceVersion="3" change="c.2073del">
            <Expression>NM_172106.3:c.2073del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_742104.1" sequenceAccession="NP_742104" sequenceVersion="1" change="p.Val692fs">
            <Expression>NP_742104.1:p.Val692fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_172107.4" sequenceAccession="NM_172107" sequenceVersion="4" change="c.2127del" MANESelect="true">
            <Expression>NM_172107.4:c.2127del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_742105.1" sequenceAccession="NP_742105" sequenceVersion="1" change="p.Val710fs">
            <Expression>NP_742105.1:p.Val710fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_172108.5" sequenceAccession="NM_172108" sequenceVersion="5" change="c.2034del">
            <Expression>NM_172108.5:c.2034del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_742106.1" sequenceAccession="NP_742106" sequenceVersion="1" change="p.Val679fs">
            <Expression>NP_742106.1:p.Val679fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA315556" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="602235.0010" DB="OMIM" />
        <XRef Type="rs" ID="118192244" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_172107.4(KCNQ2):c.2127del (p.Val710fs) AND Seizures, benign familial neonatal, 1" Accession="RCV000007814" Version="8">
        <ClassifiedConditionList TraitSetID="2010">
          <ClassifiedCondition DB="MedGen" ID="C3149074">Seizures, benign familial neonatal, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2006-09-12" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_172107.4(KCNQ2):c.2127del (p.Val710fs) AND Developmental and epileptic encephalopathy, 7" Accession="RCV000578304" Version="6">
        <ClassifiedConditionList TraitSetID="6737">
          <ClassifiedCondition DB="MedGen" ID="C3150986">Developmental and epileptic encephalopathy, 7</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-11-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_172107.4(KCNQ2):c.2127del (p.Val710fs) AND not provided" Accession="RCV000187948" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2014-07-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_172107.4(KCNQ2):c.2127del (p.Val710fs) AND Early infantile epileptic encephalopathy with suppression bursts" Accession="RCV001389321" Version="7">
        <ClassifiedConditionList TraitSetID="21987">
          <ClassifiedCondition DB="MedGen" ID="C0393706">Early infantile epileptic encephalopathy with suppression bursts</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-11" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2015-08-07" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <CitationText>Rett, A., Teubel, R. Neugeborenenkraempfe im Rahmen einer epileptisch belasteten Familie. Wien. Klin. Wschr. 76: 609-613, 1964.</CitationText>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12847176</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16260777</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16966552</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23692823</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27535030</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2847176</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20437616</ID>
          <ID Source="BookShelf">NBK32534</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2010" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5025" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Seizures, benign familial neonatal, 1</ElementValue>
                <XRef ID="MONDO:0007365" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Benign Neonatal Epilepsy 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">KCNQ2-Related Benign Familial Neonatal Epilepsy</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BFNS1</ElementValue>
                <XRef Type="MIM" ID="121200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">KCNQ2-related disorders represent a continuum of overlapping neonatal epileptic phenotypes ranging from self-limited familial neonatal epilepsy (SLFNE) at the mild end to neonatal-onset developmental and epileptic encephalopathy (NEO-DEE) at the severe end. Additional, less common phenotypes consisting of neonatal encephalopathy with non-epileptic myoclonus, infantile or childhood-onset developmental and epileptic encephalopathy (DEE), and isolated intellectual disability (ID) without epilepsy have also been described. KCNQ2-SLFNE is characterized by seizures that start in otherwise healthy infants between two and eight days after term birth and spontaneously disappear between the first and the sixth to 12th month of life. There is always a seizure-free interval between birth and the onset of seizures. Seizures are characterized by sudden onset with prominent motor involvement, often accompanied by apnea and cyanosis; video EEG identifies seizures as focal onset with tonic stiffening of limb(s) and some migration during each seizure's evolution. About 30% of individuals with KCNQ2-SLFNE develop epileptic seizures later in life. KCNQ2-NEO-DEE is characterized by multiple daily seizures beginning in the first week of life that are mostly tonic, with associated focal motor and autonomic features. Seizures generally cease between ages nine months and four years. At onset, EEG shows a burst-suppression pattern or multifocal epileptiform activity; early brain MRI can show basal ganglia hyperdensities and later MRIs may show white matter or general volume loss. Moderate-to-profound developmental impairment is present.</Attribute>
                <XRef ID="NBK32534" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20437616</ID>
                <ID Source="BookShelf">NBK32534</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="1949" DB="Orphanet" />
              <XRef ID="C3149074" DB="MedGen" />
              <XRef ID="MONDO:0007365" DB="MONDO" />
              <XRef Type="MIM" ID="121200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6737" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15768" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy 7</ElementValue>
                <XRef ID="Epileptic+encephalopathy%2C+early+infantile%2C+7/8345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 7</ElementValue>
                <XRef ID="MONDO:0013387" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">KCNQ2-Related Neonatal Epileptic Encephalopathy</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE7</ElementValue>
                <XRef Type="MIM" ID="613720" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13060" />
                <XRef ID="13060" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">KCNQ2-related disorders represent a continuum of overlapping neonatal epileptic phenotypes ranging from self-limited familial neonatal epilepsy (SLFNE) at the mild end to neonatal-onset developmental and epileptic encephalopathy (NEO-DEE) at the severe end. Additional, less common phenotypes consisting of neonatal encephalopathy with non-epileptic myoclonus, infantile or childhood-onset developmental and epileptic encephalopathy (DEE), and isolated intellectual disability (ID) without epilepsy have also been described. KCNQ2-SLFNE is characterized by seizures that start in otherwise healthy infants between two and eight days after term birth and spontaneously disappear between the first and the sixth to 12th month of life. There is always a seizure-free interval between birth and the onset of seizures. Seizures are characterized by sudden onset with prominent motor involvement, often accompanied by apnea and cyanosis; video EEG identifies seizures as focal onset with tonic stiffening of limb(s) and some migration during each seizure's evolution. About 30% of individuals with KCNQ2-SLFNE develop epileptic seizures later in life. KCNQ2-NEO-DEE is characterized by multiple daily seizures beginning in the first week of life that are mostly tonic, with associated focal motor and autonomic features. Seizures generally cease between ages nine months and four years. At onset, EEG shows a burst-suppression pattern or multifocal epileptiform activity; early brain MRI can show basal ganglia hyperdensities and later MRIs may show white matter or general volume loss. Moderate-to-profound developmental impairment is present.</Attribute>
                <XRef ID="NBK32534" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">KCNQ2-Related Disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20437616</ID>
                <ID Source="BookShelf">NBK32534</ID>
              </Citation>
              <XRef ID="439218" DB="Orphanet" />
              <XRef ID="C3150986" DB="MedGen" />
              <XRef ID="MONDO:0013387" DB="MONDO" />
              <XRef Type="MIM" ID="613720" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="21987" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32998" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy</ElementValue>
                <XRef ID="1934" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Early infantile epileptic encephalopathy with suppression bursts</ElementValue>
                <XRef ID="230429005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ohtahara syndrome</ElementValue>
                <XRef ID="1934" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Developmental and epileptic encephalopathy</ElementValue>
                <XRef ID="MONDO:0100062" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EIEE</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9255" />
                <XRef ID="9255" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1934" DB="Orphanet" />
              <XRef ID="C0393706" DB="MedGen" />
              <XRef ID="MONDO:0100062" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS308350" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="41629" SubmissionDate="2016-03-31" DateLastUpdated="2022-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_172107.2:c.2127delT|OMIM:121200" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV000041629" DateUpdated="2022-10-01" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12847176</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16260777</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16966552</ID>
          </Citation>
          <Citation>
            <ID Source="BookShelf">NBK32534</ID>
          </Citation>
          <Comment>BFNE (benign familial neonatal epilepsy)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Val710SerfsTer219</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_172107.2:c.2127delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3149074" Type="CUI" />
          </Trait>
        </TraitSet>
        <Comment>Functional effect: Lack of functional homomeric channels; reduction in current amplitude of heteromeric channels; decreased protein stability and enhanced degradation</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="446274" SubmissionDate="2015-07-30" DateLastUpdated="2015-08-07" DateCreated="2015-08-07">
        <ClinVarSubmissionID localKey="28991" />
        <ClinVarAccession Accession="SCV000241551" DateUpdated="2015-08-07" DateCreated="2015-08-07" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-07-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>c.2127delT: p.Val710SerfsX220 (V710SfsX220) in exon 17 of the KCNQ2 gene (NM_172107.2). The normal sequence with the base that is deleted in braces is: GCCCCC{T}GTCC.The c.2127delT mutation in the KCNQ2 gene has been reported previously in association with benign familial neonatal seizures (Coppola et al., 2003). The deletion causes a frameshift starting with codon Valine 710, changes this amino acid to a Serine residue and creates a premature Stop codon at position 220 of the new reading frame, denoted p.Val710SerfsX220. This results in the replacement of the last 163 amino acids of the KCNQ2 protein with 219 incorrect amino acids. The variant is found in INFANT-EPI panel(s).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.V710SfsX220</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_172107.2:c.2127delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="483897" SubmissionDate="2015-11-25" DateLastUpdated="2016-01-22" DateCreated="2016-01-22">
        <ClinVarSubmissionID localKey="NM_172107.2:c.2127delT|OMIM:121200" />
        <ClinVarAccession Accession="SCV000258977" DateUpdated="2016-01-22" DateCreated="2016-01-22" Type="SCV" Version="1" SubmitterName="NeuroMeGen, Hospital Clinico Santiago de Compostela" OrgID="505605" OrganizationCategory="clinic" OrgAbbreviation="NeuroMeGen" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_172107.2:exon 17</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_172107.2:c.2127delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="121200" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="28019" SubmissionDate="2018-01-17" DateLastUpdated="2018-01-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602235.0010_SEIZURES, BENIGN FAMILIAL NEONATAL, 1" title="KCNQ2, 1-BP DEL, 2127T_SEIZURES, BENIGN FAMILIAL NEONATAL, 1" />
        <ClinVarAccession Accession="SCV000028019" DateUpdated="2018-01-20" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-09-12">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a family with benign familial neonatal seizures (BFNS1; 121200), originally reported by Rett and Teubel (1964), Zimprich et al. (2006) identified a heterozygous 1-bp deletion (2127delT) in the last exon of the KCNQ2 gene, resulting in a replacement of the C terminus with 219 new amino acids and a protein that is 56 residues longer than the wildtype protein. Three of the 9 affected individuals later developed childhood nocturnal generalized tonic-clonic seizures; 2 of the 3 also had simple focal orofacial seizures.</Attribute>
              <Citation>
                <CitationText>Rett, A., Teubel, R. Neugeborenenkraempfe im Rahmen einer epileptisch belasteten Familie. Wien. Klin. Wschr. 76: 609-613, 1964.</CitationText>
              </Citation>
              <Citation>
                <ID Source="PubMed">16966552</ID>
              </Citation>
              <XRef DB="OMIM" ID="121200" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ2" />
          </GeneList>
          <Name>KCNQ2, 1-BP DEL, 2127T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 2127T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602235.0010" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SEIZURES, BENIGN FAMILIAL NEONATAL, 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1334645" SubmissionDate="2017-12-18" DateLastUpdated="2018-02-08" DateCreated="2018-02-08">
        <ClinVarSubmissionID localKey="141-20171218" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000680269" DateUpdated="2018-02-08" DateCreated="2018-02-08" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München" OrgID="500240" OrganizationCategory="clinic" OrgAbbreviation="IHG-MRI-TUM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Classification criteria August 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/inodbbrd/classification_criteria.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Tissue>blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
              <FamilyData PedigreeID="269" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">269</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="20" alternateAllele="C" referenceAllele="CA" start="62038488" stop="62038489" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613720" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3116318" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4960917|MedGen:C0393706" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001590644" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">2847176</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16260777</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12847176</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16966552</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27535030</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23692823</ID>
          </Citation>
          <Comment>Experimental studies have shown that this frameshift affects KCNQ2 function (PMID: 2847176, 16260777). This sequence change results in a frameshift in the KCNQ2 gene (p.Val710Serfs*220). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 163 amino acid(s) of the KCNQ2 protein and extend the protein by 56 additional amino acid residues. This variant is not present in population databases (gnomAD no frequency). This frameshift has been observed in individuals with benign familial neonatal convulsions (PMID: 12847176, 16966552, 27535030). This variant is also known as c.2043del. ClinVar contains an entry for this variant (Variation ID: 7390). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. This variant disrupts a region of the KCNQ2 protein in which other variant(s) (p.Cys774Leufs*91) have been determined to be pathogenic (PMID: 23692823). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.10:g.62038489del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0393706" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="483897" TraitType="Disease" MappingType="XRef" MappingValue="121200" MappingRef="OMIM">
        <MedGen CUI="C3149074" Name="Seizures, benign familial neonatal, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="446274" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3116318" TraitType="Disease" MappingType="XRef" MappingValue="C0393706" MappingRef="MedGen">
        <MedGen CUI="C0393706" Name="Early infantile epileptic encephalopathy with suppression bursts" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="41629" TraitType="Disease" MappingType="XRef" MappingValue="C3149074" MappingRef="MedGen">
        <MedGen CUI="C3149074" Name="Seizures, benign familial neonatal, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1334645" TraitType="Disease" MappingType="XRef" MappingValue="613720" MappingRef="OMIM">
        <MedGen CUI="C3150986" Name="Developmental and epileptic encephalopathy, 7" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="28019" TraitType="Disease" MappingType="Name" MappingValue="SEIZURES, BENIGN FAMILIAL NEONATAL, 1" MappingRef="Preferred">
        <MedGen CUI="C3149074" Name="Seizures, benign familial neonatal, 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

